scispace - formally typeset
R

Rachel E. Dew

Researcher at Duke University

Publications -  29
Citations -  787

Rachel E. Dew is an academic researcher from Duke University. The author has contributed to research in topics: Mental health & Substance abuse. The author has an hindex of 13, co-authored 29 publications receiving 679 citations. Previous affiliations of Rachel E. Dew include Baptist Memorial Hospital-Memphis & Wake Forest Baptist Medical Center.

Papers
More filters
Journal ArticleDOI

Religion/Spirituality and Adolescent Psychiatric Symptoms: A Review

TL;DR: Evidence for relationships between greater religiousness and less psychopathology was strongest in the area of teenage substance use and methods of measuring religion/spirituality were highly heterogeneous.
Journal ArticleDOI

Religious and Spiritual Factors in Depression: Review and Integration of the Research

TL;DR: Understanding the role that R/S factors play in preventing depression, facilitating its resolution, or leading to greater depression will help clinicians determine whether this is a resource or a liability for individual patients.
Journal ArticleDOI

A prospective study of religion/spirituality and depressive symptoms among adolescent psychiatric patients

TL;DR: Several aspects of religiousness/spirituality appear to relate cross-sectionally to depressive symptoms in adolescent psychiatric patients, but perceived social support and substance abuse account for some of these correlations but do not explain relationships to negative religious coping, loss of faith, or forgiveness.
Journal ArticleDOI

Religion, spirituality, and depression in adolescent psychiatric outpatients.

TL;DR: Clinicians should assess religious beliefs and perceptions of support from the religious community as factors intertwined with the experience of depression, and consider the most appropriate ways of addressing these factors that are sensitive to adolescents' and families' religious values and beliefs.
Journal ArticleDOI

Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity Disorder

TL;DR: In this paper, the authors consider relevant neurobiological underpinnings of ADHD with respect to why α-2 agents may be effective in treating this condition and also review new formulations of α2 agonists, emerging data on their use in ADHD, and implications for clinical practice.